Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmala Foods Plc Regulatory News (DISH)

  • This share is currently suspended. It was suspended at a price of 0.1367

Share Price Information for Amala Foods Plc (DISH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1367
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.1367
DISH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report for period 30 September 2022

31 Mar 2023 12:37

RNS Number : 9776U
Amala Foods PLC
31 March 2023
 

Amala Foods Plc

("Amala" or the "Company")

 

Half Yearly Financial Report Ended 30 September 2022

 

Amala Foods Plc (LON: DISH), a cash shell company, is pleased to announce the publication of the Half Yearly Financial Report for the period ended 30 September 2022 which is below this announcement. The Half Yearly Financial Report will also shortly be available via the National Storage Mechanism.

The Company will now make application to the FCA for the listing to be restored.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 ("MAR").

 

 

Enquiries:

 

Jonathan Morley-Kirk, Non-Executive Chairman

jmk@bluebirdmv.com

 

 

REPORT OF THE DIRECTORS

 

The Directors present the report together with the unaudited interim financial statements for the Company for the half-year ended 30 September 2022.

 

The Company

 

Amala Foods Plc is registered (registered number 121041) and domiciled in Jersey. It was incorporated on 11 April 2016.

 

Principal Activity and Business Review

 

The Company's principal activity during the period ended 30 September 2022 was a cash shell company. The Company signed a Share Purchase Agreement with Terra Rara UK Ltd that would have resulted in a Reverse Takeover. The proposed transaction was terminated after the period. The Directors are actively seeking new opportunities that will lead to a Reverse Takeover.

 

Results and Dividends

 

The results of the Company for the half-year ended 30 September 2022 show a loss before taxation of GBP 82,631 (30 September 2021 showed a loss of GBP 60,101).

 

No dividends have been paid during the half-year ended 30 September 2022 or during the comparative period.

 

The Directors note that the 30 September 2021 comparatives are re-stated in this half yearly report as they reflect the Company results only as it had no subsidiaries or associates at the end of 30 September 2022 or 30 September 2021.

 

Principal Risks and Uncertainties

 

The principal business risks that have been identified are as below.

 

Transaction Risk

 

There is no guarantee that a suitable transaction will be identified and will be successfully completed, resulting in a Reverse Takeover. Even if a transaction is successful, there is no guarantee that the Directors will be successful in managing the new business and derive the value that is hoped. Should a transaction not complete, once identified, then the Directors will need to invest further time and resources in identifying another suitable target company.

 

Funding Risk

 

The Company has not yet achieved profitability and is therefore reliant on periodically raising finance to fund its expenditure. There can be no guarantees that additional capital will be available when required. Whilst the Company raised GBP 405,000 in Convertible Loan Notes after the period, there is no guarantee that further capital will be available if and when required to complete a transaction that will result in a Reverse Takeover or that further capital will be available to fund an enlarged group after the completion of a transaction. The Directors have taken steps to conserve cash including not receiving any remuneration until there is a successful Reverse Takeover.

 

Key Personnel Risk

 

The Company is dependent on the experience and abilities of its Directors. Whilst the Company does not expect any of the Directors to leave the Company, if such individuals were to leave the Company, and the Company was unable to attract suitable experienced personnel, it could have a negative impact on the future prospects of the Company.

 

Events after the Reporting Period

 

Refer note 9 of the unaudited interim financial statements.

 

 

Company Directors

 

 

Position

 

Appointment Date

Audit

Committee

Remuneration Committee

Jonathan Morley-Kirk

Non-Executive Chairman

16 April 2016

Aidan Bishop

Executive Director

16 April 2016

-

-

 

Note: Celia Li was appointed as a Non-Executive Director on 17 March 2023 and will join the Remuneration Committee.

 

Share Capital

 

At 30 September 2022, the issued share capital of the Company stood at 443,620,823 - with no new shares having been issued during the period.

 

This Directors' Report was approved by the Board of Directors on 31 March 2023 and is signed on its behalf.

 

By Order of the Board

 

 

 

 

Jonathan Morley-Kirk

Chairman

31 March 2023

STATEMENT OF COMPREHENSIVE INCOME

For the half-year ended 30 September 2022

 

30 Sep 2022 30 Sep 2021

(unaudited) (unaudited)

Note GBP GBP

 

Administrative expenses (91,327) (96,302)

Interest income - 9,707

Fair value gain 7 8,696 66,494

Impairment expenses - (40,000)

 

 

Loss before taxation (82,631) (60,101)

 

 

Income tax expense - -

 

 

Loss for the period 4 (82,631) (60,101)

 

 

Earnings per share:

Basic and diluted loss per share 6 (0.0002) (0.0002)

 

 

The accompanying notes form an integral part of these financial statements.

 

 

 

 

STATEMENT OF FINANCIAL POSITION

at 30 September 2022

30 Sep 2022 30 Sep 2021

(unaudited) (unaudited)

Note GBP GBP

 

 

Current assets

 

Trade and other receivables 5 94,675 34,656

Cash and cash equivalents 10,743 212,005

 

105,418 246,661

Current liabilities

 

Trade and other payables (101,335) (90,000)

Borrowings (627,537) (450,000)

 

(728,872) (540,000)

 

 

Net assets/(liabilities) (623,454) (293,339)

 

Equity

 

Issued share capital 6 6,488,490 6,287,269

Retained earnings (8,883,963) (7,783,516)

Other Reserves 8 1,772,019 1,202,908

 

 

Total equity (623,454) (293,339)

 

 

The accompanying notes form an integral part of these financial statements.

 

These financial statements were approved by the Board of Directors.

 

 

 

 

 

Jonathan Morley-Kirk

Chairman

31 March 2023

 

 

STATEMENT OF CHANGES IN EQUITY

at 30 September 2022

Share Retained Other Total Capital Earnings Reserves Equity

GBP GBP GBP GBP

 

 

At 31 March 2021 (unaudited) 6,455,154 (7,723,415) 1,306,142 37,881

 

 

Loss for the period - (60,101) - (60,101)

 

 

Total comprehensive income for the period - (60,101) - (60,101)

 

 

Issue of new ordinary shares (net)  (167,885) - - (167,885)

Reserves - - (103,234) (103,234)

 

Total transactions with owners (167,885) - (103,234) (271,119)

 

 

At 30 September 2021 (unaudited) 6,287,269 (7,783,516) 1,202,908 (293,339)

 

 

Loss for the period - (1,017,816) - (1,017,816)

 

 

Total comprehensive income for the period - (1,017,816) - (1,017,816)

 

 

Issue of new ordinary shares (net)  201,221 - - 201,221

Reserves - - 511,807 511,807

 

Total transactions with owners 201,221  - 511,807 713,028

 

 

At 31 March 2022 6,488,490 (8,801,332) 1,714,715 (598,127)

 

 

Loss for the period - (82,631) - (82,631)

 

 

Total comprehensive income for the period - (82,631) - (82,631)

 

 

Warrants reserves - - (8,696) (8,696)

Shares to be issued reserve - - 66,000 66,000

 

Total transactions with owners - - 57,304 57,304

 

 

At 30 September 2022 (unaudited) 6,488,490 (8,883,963) 1,772,019 (623,454)

 

 

 

 

The accompanying notes form an integral part of these financial statements.

CASH FLOW STATEMENT

For the half-year ended 30 September 2022

 

30 Sep 2022 30 Sep 2021

(unaudited) (unaudited)

Note GBP GBP

 

 

Cash flows from operating activities

 

Cash paid to suppliers & employees (9,124) (139,838)

 

 

Net cash from operating activities (9,124) (139,838)

 

 

Cash flows from financing activities

 

Loan received - 246,284

 

 

Net cash used in financing activities - 246,284

 

Net increase (decrease) in cash (9,124) 106,446

 

 

Cash and cash equivalents at start of period 19,867 105,559

Cash and cash equivalents at end of the period 10,743 212,005

 

The accompanying notes form an integral part of these financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

For the half-year ended 30 September 2022

 

1. BASIS OF PREPARATION AND ADOPTION OF INTERNATIONAL FINANCIAL REPORTING STANDARDS (IFRS)

 

The interim financial statements have been prepared in accordance with the recognition and measurement principles of UK adopted International Accounting Standards and expected to be effective at the year-end of 31 March 2023. The accounting policies are unchanged from the financial statements for the year ended 31 March 2022. The interim financial statements, which have been prepared in accordance with International Accounting Standard 34 (IAS 34) as adopted by the European Union, are unaudited. Accounts for the year ended 31 March 2022, prepared in accordance with IFRS, have been filed. The Auditors' Report on these accounts was unqualified, but did include a material uncertainty in respect of going concern.

 

The interim financial statements are for the six months to 30 September 2022. The interim consolidated financial information does not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Company's annual financial statements for the year ended 31 March 2022, which were prepared in accordance with UK adopted International Accounting Standards.

 

 

2. GOING CONCERN

 

The Company entered into a Deed of Standstill with a creditor to reprofile outstanding debt to a reduced amount of GBP 690,000 that would convert to shares at the re-admission price upon a Reverse Takeover and that no interest will accrue and for all existing warrants to be cancelled upon a Reverse Takeover. Should a Reverse Takeover not take place by 22 September 2023 then the creditor may call upon cash repayment.

 

Furthermore, after the balance sheet date, the Company announced that it raised GBP 405,000 in Convertible Loan Notes that would be largely utilised to fund a transaction leading to a Reverse Takeover. These Convertible Loan Notes are automatically converted into shares upon a Reverse Takeover. However, the holders of the convertible loan notes may call upon cash repayment between April and the end of June 2023 should there be no Reverse Takeover .

 

Having prepared and reviewed cashflow forecasts, the Directors have ascertained that further finance will need to be raised should the convertible loans be required to be repaid in cash in the next 12 months. The Directors are confident that should the convertible loan notes, in part or in full, require repayment then they would be able to raise sufficient funds to be able to make such repayments whilst still funding the Company's forecasted expenditure. However, as completion of a reverse takeover by the required dates and thus avoiding cash repayment of the convertible loan notes is not guaranteed and given the requirement to raise further funds in such an event, next 12 months, they acknowledge that a material uncertainty relating to going concern exists.

 

The Directors have agreed to not receiving any remuneration due to them as at 30 September 2022 and for their services provided during the period of the suspension of the listing and until a successful transaction is completed that results in a Reverse Takeover.

 

The accounts have therefore been prepared on a going concern basis.

 

 

3. SEGMENTAL REPORTING

 

The Company's operating segments are based on geographical location and determined solely as Jersey.

 

 

4. LOSS FOR THE PERIOD BEFORE TAX

 

30 Sep 2022 30 Sep 2021

(unaudited) (unaudited)

GBP GBP

 

 

Loss for the period has been arrived at after charging:

Directors remuneration 70,000 70,000

 

After the period end date, the Directors agreed to receive no remuneration that was due and to receive no further remuneration until a successful transaction resulting in a Reverse Takeover is achieved.

 

5. TRADE AND OTHER RECEIVABLES

 

30 Sep 2022 30 Sep 2021

(unaudited) (unaudited)

GBP GBP

 

 

Prepaid Consideration - Amala Foods Inc - 34,656

Investment - Terra Rara UK Ltd 94,675 -

 

 

Balance at end of period 94,675 34,656

 

 

Prepaid Consideration - Amala Food Inc was written off as detailed in the 31 March 2022 Annual Report.

 

Loan receivables at 30 September 2022 relates to USD 125,000 loaned to Terra Rara UK Ltd on 22 February 2022 with a 1 year term and carries a 0.5% interest rate. On 17 March 2023, the Company announced that the proposed acquisition of Terra Rara UK Ltd was terminated.

 

 

6. SHARE CAPITAL

 

6.1 Share Capital

30 Sep 2022 30 Sep 2021

(unaudited) (unaudited)

Number GBP Number GBP

 

 

Opening balance 373,620,823 6,287,269 348,950,355 5,972,980

Ordinary shares - new shares issued during the period 70,000,000 210,000 24,670,468 471,690

Loan receivables settlement and adjustments - (8,759) - (157,401)

 

 

Closing balance 443,620,823 6,488,490 373,620,823 6,287,269

 

 

The shares have no par value. The Group holds 19,607,383 shares in treasury (30 September 2021, 11,000,000).

 

6.2 Earnings Per Share

30 Sep 2022

(unaudited)

GBP

30 Sep 2021 (unaudited)

GBP

 

Basic and diluted earnings per share

 

(0.0002)

 

(0.0002)

Loss used to calculate basic and diluted earnings per share

(82,631)

(60,101)

Weighted average number of shares used in calculating basic and diluted earnings per share

443,620,823

373,620,823

 

Earnings per share is calculated by dividing the loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding and shares to be issued during the period.

 

In 2022 and 2021, the potential ordinary shares were anti-dilutive as the Group was in a loss making position and therefore the conversion of potential ordinary shares would serve to decrease the loss per share from continuing operations. Where potential ordinary shares are anti-dilutive a diluted earnings per share is not calculated and is deemed to be equal to the basic earnings per share.

 

The warrants noted in note 7 could potentially dilute EPS in the future.

 

 

 

7. SHARE WARRANTS

 

Warrants are denominated in Sterling and are issued for services provided to the Company

Warrants at 30 September 2022:

 

 

 

Exercise price

No. issued and exercisable at 01 Apr 2022

 

No. exercised in period

 

No. lapsed in period

No. outstanding and exercisable at 30 Sep 2021

 

Expiry date

1.35p

4,324,320

-

-

4,324,320

19 October 2023

1.10p

5,404,400

-

-

5,404,400

19 November 2023

1.15p

43,478,260

-

-

43,478,260

16 July 2025

Closing balance

53,206,980

-

-

53,206,980

 

 

 

8. RESERVES

 

 

30 Sep 2022

(unaudited)

GBP

30 Sep 2021

(Re-stated

unaudited)

GBP

 

Share options reserve

 

977,617

 

949,733

Warrants reserve

Shares to be issued reserve

 

372.463

421,939

23,239

229,936

 

Balance at end of period

 

1,772,019

 

1,202,908

 

 

9. EVENTS AFTER THE REPORTING PERIOD

 

The Company announced on 17 March 2023 that the proposed acquisition of Terra Rara UK Ltd (announced on 23 May 2022) was terminated. The Directors determine this to be a non-adjusting event due to their being no intention or negotiations as at 31 March 2022 to terminate the transaction and therefore no adjustments have been made to the balance due from Terra Rara UK Ltd as at 31 March 2022 as a result of this subsequent event.

 

The Company entered into a Deed of Standstill with a creditor to reprofile outstanding debt to a reduced amount of GBP 690,000 that would convert to shares at the re-admission price upon a Reverse Takeover and that no interest will accrue and for all existing warrants to be cancelled upon a Reverse Takeover.

 

The Company announced on 17 March 2023 that GBP 405,000 had been raised via Convertible Loan Notes to fund a transaction leading to a Reverse Takeover. The Convertible Loan Notes will automatically convert to shares upon a successful Reverse Takeover at a 50% discount to the Readmission should a Reverse Takeover be achieved by April 2023 and will be repayable in cash if not.

 

The Directors agreed to receive no remuneration that was due and to receive no further remuneration until a successful transaction resulting in a Reverse Takeover is achieved.

 

The Company announced on 17 March 2023 the appointment of Celia Li to the Board as a Non-Executive Director.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR JBMBTMTBJBMJ
Date   Source Headline
24th Apr 20247:00 amRNSTransaction Update
4th Jan 20247:00 amRNSResult of AGM
1st Dec 20233:01 pmRNSFurther re Temporary Suspension
9th Nov 202312:00 pmRNSTemporary Suspension
9th Nov 20237:00 amRNSHalf-year Report
31st Jul 20234:30 pmRNSAnnual Financial Report
9th May 20237:00 amRNSFurther re Corporate Update
19th Apr 20237:00 amRNSCorporate Update
18th Apr 20237:30 amRNSRestoration - Amala Foods plc
31st Mar 202312:37 pmRNSHalf-year Report for period 30 September 2022
31st Mar 202312:35 pmRNSAnnual Financial Report 2022
17th Mar 20238:00 amRNSCorporate Update
4th Jan 20237:00 amRNSResult of AGM
22nd Dec 20228:00 amRNSNotice of AGM
23rd May 20227:35 amRNSSuspension Of Listing And Proposed Acquisition
23rd May 20227:30 amRNSSuspension - Amala Foods plc
25th Mar 20228:56 amRNSTR-1 Notification of Major Holdings
16th Mar 20227:45 amRNSRare Earth Elements Potential Transaction Update
10th Mar 20227:00 amRNSRare Earth Elements Market Opportunity
2nd Mar 202211:05 amRNSSecond Price Monitoring Extn
2nd Mar 202211:00 amRNSPrice Monitoring Extension
2nd Mar 20229:33 amRNSFurther re Corporate Update
28th Feb 20227:00 amRNSStatement re Corporate Update
22nd Feb 20227:00 amRNSHolding(s) in Company
17th Feb 202211:05 amRNSSecond Price Monitoring Extn
17th Feb 202211:00 amRNSPrice Monitoring Extension
17th Feb 202210:00 amRNSCorporate Update
31st Jan 202210:00 amRNSHalf-year Report
10th Jan 20227:00 amRNSAGM Results
20th Dec 20217:00 amRNSNotice of AGM
17th Dec 20217:00 amRNSTR-1 Notification of Major Holdings
8th Dec 20217:00 amRNSIssue of Equity
6th Dec 20212:06 pmRNSSecond Price Monitoring Extn
6th Dec 20212:00 pmRNSPrice Monitoring Extension
3rd Dec 20217:44 amRNSFurther re: Annual Financial Report
2nd Dec 20217:30 amRNSAnnual Financial Report 2021
9th Nov 20217:00 amRNSStatement re Audit Process and Operational Update
30th Sep 20217:00 amRNS2021 Annual Financial Report Publication Update
22nd Sep 20217:00 amRNSNew Company Website
9th Aug 20217:00 amRNSBusiness Update
23rd Jun 20217:00 amRNSOperational Update
2nd Jun 20217:00 amRNSOperational Update
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20212:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20212:01 pmRNSPrice Monitoring Extension
22nd Mar 20217:00 amRNSResult of General Meeting
1st Mar 20214:40 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
25th Feb 20217:00 amRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.